Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Alrubia

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Medicina (Kaunas, Lithuania)|October 26, 2024
A Simple Eco-Friendly HPLC-PDA Method for the Simultaneous Determination of Paclitaxel and Seliciclib in Plasma Samples for Assessing Their Pharmacodynamics and Pharmacokinetics in Combination Therapy for Uterine SarcomaAmsha S Alsegiani, Sarah Alrubia, Ibrahim A Darwish
Acta Pharmaceutica (Zagreb, Croatia)|June 3, 2025
Development of two different eco-friendly label-free platforms for analysis of selumetinibSarah Alrubia, Wafa A Alshehri, Nourah Z Alzoman, et al.
Analytical Biochemistry|February 13, 2025
A sensitive HPLC method with fluorescence detection for quantification of pemigatinib in human plasma samples and its in-vivo application to pharmacokinetic study in ratsSarah Alrubia, Amsha S Alsegiani, Nourah Z Alzoman, et al.
Clinical Pharmacokinetics|September 2, 2022
Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered DrugsSarah Alrubia, Jialin Mao, Yuan Chen, et al.
Journal of Pharmaceutical Sciences|July 25, 2022
Quantitative Assessment of the Impact of Crohn's Disease on Protein Abundance of Human Intestinal Drug-Metabolising Enzymes and TransportersSarah Alrubia, Zubida M Al-Majdoub, Brahim Achour, et al.
BMC Pharmacology & Toxicology|July 2, 2025
Comparative analysis of safety and efficacy between brand and generic lamotrigine products in the Saudi marketHaya Alotaibi, Sarah Sulaiman Alenazi, Sarah Alrubia, et al.
British Journal of Clinical Pharmacology|March 5, 2025
Variability in intestinal drug metabolizing enzymes and transporters in Crohn's disease and potential impact on oral drug absorptionSarah Alrubia, Brahim Achour, Zubida M Al-Majdoub, et al.
BMC Chemistry|January 29, 2025
Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulationSarah Alrubia, Wafa A AlShehri, Awwad A Radwan, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|November 13, 2018
Physical and chemical screening of honey samples available in the Saudi market: An important aspect in the authentication process and quality assessmentHaya I Aljohar, Hadir M Maher, Jawza Albaqami, et al.
Journal of Proteomics|March 30, 2022
A family of QconCATs (Quantification conCATemers) for the quantification of human pharmacological target proteinsAreti-Maria Vasilogianni, Eman El-Khateeb, Brahim Achour, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Medicina (Kaunas, Lithuania)|October 26, 2024
A Simple Eco-Friendly HPLC-PDA Method for the Simultaneous Determination of Paclitaxel and Seliciclib in Plasma Samples for Assessing Their Pharmacodynamics and Pharmacokinetics in Combination Therapy for Uterine SarcomaAmsha S Alsegiani, Sarah Alrubia, Ibrahim A Darwish
Acta Pharmaceutica (Zagreb, Croatia)|June 3, 2025
Development of two different eco-friendly label-free platforms for analysis of selumetinibSarah Alrubia, Wafa A Alshehri, Nourah Z Alzoman, et al.
Analytical Biochemistry|February 13, 2025
A sensitive HPLC method with fluorescence detection for quantification of pemigatinib in human plasma samples and its in-vivo application to pharmacokinetic study in ratsSarah Alrubia, Amsha S Alsegiani, Nourah Z Alzoman, et al.
Clinical Pharmacokinetics|September 2, 2022
Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered DrugsSarah Alrubia, Jialin Mao, Yuan Chen, et al.
Journal of Pharmaceutical Sciences|July 25, 2022
Quantitative Assessment of the Impact of Crohn's Disease on Protein Abundance of Human Intestinal Drug-Metabolising Enzymes and TransportersSarah Alrubia, Zubida M Al-Majdoub, Brahim Achour, et al.
BMC Pharmacology & Toxicology|July 2, 2025
Comparative analysis of safety and efficacy between brand and generic lamotrigine products in the Saudi marketHaya Alotaibi, Sarah Sulaiman Alenazi, Sarah Alrubia, et al.
British Journal of Clinical Pharmacology|March 5, 2025
Variability in intestinal drug metabolizing enzymes and transporters in Crohn's disease and potential impact on oral drug absorptionSarah Alrubia, Brahim Achour, Zubida M Al-Majdoub, et al.
BMC Chemistry|January 29, 2025
Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulationSarah Alrubia, Wafa A AlShehri, Awwad A Radwan, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|November 13, 2018
Physical and chemical screening of honey samples available in the Saudi market: An important aspect in the authentication process and quality assessmentHaya I Aljohar, Hadir M Maher, Jawza Albaqami, et al.
Journal of Proteomics|March 30, 2022
A family of QconCATs (Quantification conCATemers) for the quantification of human pharmacological target proteinsAreti-Maria Vasilogianni, Eman El-Khateeb, Brahim Achour, et al.
Pageof 3